SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Trading Statement

13 Dec 2007 07:01

Rentokil Initial PLC13 December 2007 13 December 2007 RENTOKIL INITIAL PLC (RTO) TRADING UPDATE In our third quarter trading update for the period to 30 September 2007 we saidthat while business to business trading in City Link, our express parcelsdelivery business, had shown good year-on-year growth, the business to consumer(B to C) segment had softened over the quarter. This was a continuation of whatwe believe to be an industry wide trend. Operational performance within City Link is strong with service levels higherthan this time last year. Customer retention levels remain good and we continueto win new business. However, during the fourth quarter, the anticipated surgein volumes seen in prior years in the B to C segment in the run up to Christmashas been later and less than expected. B to C volumes have slipped below thelevel experienced this time last year, and business to business volumes, whichhad been significantly ahead, are now in line with last year's levels. As aresult fourth quarter profits from City Link are likely to be up to £10 millionbelow our expectations. This will have a similar impact on the results for thegroup as a whole. As we said at the time of our third quarter update on 8 November we believe thatthis slowdown in B to C volumes is a direct result of weaker consumer spendingin a challenging retail environment. Progress on the integration of TargetExpress continues to deliver synergy benefits ahead of original plan and in linewith the Q3 statement. The physical integration of depots will commence inJanuary 2008. Trading in our other divisions remains in line with our expectations. Rentokil Initial plc's Preliminary results for the 12 months to 31 December 2007will be announced on Tuesday, 26 February 2008. Enquiries: Shareholder/analyst enquiries:Andrew Macfarlane, Chief Financial OfficerKatharine Rycroft, Head of Investor Relations Rentokil Initial plc 020 7592 2700 Media enquiries:Malcolm Padley, Head of Corporate Communications Rentokil Initial plc 07788 978199Kate Holgate / Tom Williams Brunswick Group 020 7404 5959 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
29th Aug 20187:00 amRNSDirector/PDMR Shareholding
20th Aug 201812:44 pmRNSDirector/PDMR Shareholding
1st Aug 20183:12 pmRNSHolding(s) in Company
31st Jul 20187:00 amRNSInterim Results
27th Jul 20185:07 pmRNSHolding(s) in Company
5th Jul 20184:52 pmRNSHolding(s) in Company
5th Jul 201811:36 amRNSDirector Declaration
28th Jun 20184:10 pmRNSHolding(s) in Company
7th Jun 20185:16 pmRNSDirector Declaration
17th May 20184:12 pmRNSDirector/PDMR Shareholding
16th May 20187:00 amRNSNotice of Capital Markets Days
9th May 20185:40 pmRNSResult of AGM
4th May 20184:27 pmRNSDirector/PDMR Shareholding
2nd May 201810:52 amRNSDirector/PDMR Shareholding
1st May 20186:00 pmRNSDirector/PDMR Shareholding
30th Apr 20185:48 pmRNSDirector/PDMR Shareholding
26th Apr 20183:24 pmRNSHolding(s) in Company
25th Apr 20184:50 pmRNSHolding(s) in Company
24th Apr 20183:55 pmRNSHolding(s) in Company
24th Apr 201810:53 amRNSHolding(s) in Company
20th Apr 20184:09 pmRNSDirector/PDMR Shareholding
19th Apr 20184:32 pmRNSHolding(s) in Company
19th Apr 20187:00 amRNSQ1 Trading Update
5th Apr 201812:57 pmRNSHolding(s) in Company
5th Apr 201811:06 amRNSAnnual Financial Report
4th Apr 20186:01 pmRNSDirector/PDMR Shareholding
3rd Apr 20184:12 pmRNSBlock listing Interim Review
29th Mar 201811:55 amRNSTotal Voting Rights
27th Mar 20184:01 pmRNSHolding(s) in Company
27th Mar 201812:58 pmRNSAdditional Listing
8th Mar 20185:50 pmRNSDirector/PDMR Shareholding
1st Mar 20187:00 amRNSFinal Results
27th Dec 20177:00 amRNSDirector/PDMR Shareholding
20th Dec 20173:40 pmRNSDirector/PDMR Shareholding
22nd Nov 20174:30 pmRNSHolding(s) in Company
17th Nov 20177:00 amRNSIssue of new EUR400m bond
13th Nov 20174:35 pmRNSHolding(s) in Company
13th Nov 20177:00 amRNSPurchase of Vector Disease Acquisition LLC
7th Nov 20174:14 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSDirectorate Change
2nd Nov 20176:07 pmRNSHolding(s) in Company
1st Nov 20177:00 amRNSDirectorate Change
19th Oct 20177:00 amRNSQ3 Trading Update
2nd Oct 20173:26 pmRNSBlock listing Interim Review
21st Sep 20177:00 amRNSDirectorate Change
18th Sep 20177:00 amRNSDirectorate Change
22nd Aug 20173:34 pmRNSChange to Director's details
4th Aug 201711:57 amRNSDirector/PDMR Shareholding
31st Jul 20172:16 pmRNSDirector Declaration
27th Jul 20177:00 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.